Hospital News, Research & Data Analysis
In Beth Israel Deaconess Medical Center
By: Sara Riascos Mar. 03, 2022
Major Joint Replacement is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. XARELTO(Rivaroxaban) is a factor XA inhibitor prescribed by doctors to prevent blood clots from irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Studies have shown that the early use of XARELTO(Rivaroxaban) after a Major joint replacement surgery is associated with decreased the rate of symptomatic VTE. Other studies have shown that XARELTO(Rivaroxaban) had a superior effect in THA patients. Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of XARELTO(Rivaroxaban) within 7 days of hospitalization was associated with lower hospital readmission rates for Major Joint Replacement at Bethesda Hospital at Boynton Beach, Florida. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.
Read moreBeth Israel Deaconess Medical Center’s Renal Failure MSPB average increased by almost 22%
In Beth Israel Deaconess Medical Center
By: Barsha Nandy Oct. 12, 2020
Dexur analyzed Medicare Claims data and replicated CMS algorithms to calculate Medicare Spending per Beneficiary (MSPB) cost per episode of Beth Israel Deaconess Medical Center and found that the cost per episode was $33,869 for Renal Failure from Jan-Dec 2019. The cost increased by 21.68% in 2019 to $33,869 compared to $27,834 in 2018. MSPB is the only measure under the Efficiency and Cost Reduction domain under the Value-Based Purchasing (VBP) Program and accounts for 25% of VBP adjustments.
Beth Israel Deaconess Medical Center Has 3 of the Top 10 Cardiovascular Physicians in Massachusetts
In Beth Israel Deaconess Medical Center
By: Emily Carpintero Oct. 16, 2017
Beth Israel Deaconess Medical Center, located in Boston, Massachusetts, has some of the most successful cardiovascular and cardiothoracic physicians in the state. In 2007, BIDMC combined its 3 divisions of Cardiovascular Medicine, Cardiac Surgery and Vascular and Endovascular Surgery into what is now BIDMC's Cardiovascular Institute. Most of their physicians are also engaged in current studies and research, allowing them to provide their patients with modern clinical trials and treatments. In the chart below, provided by our Dexur analysts, are the discharge statistics for Dr. Venkatachalam Senthilnathan, Dr. David C. Liu and Dr. Kamal R. Khabbaz - each responsible for over 0.2% of all Medicare inpatient discharges for cardiovascular procedures. Read more